Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
Completed · Not applicable
Conditions studied: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
In brief
The purpose of this is to formally assess health literacy and medication adherence in participants with Inflammatory bowel disease (IBD). The study also aims to improve medication adherence, health-related quality of life, and disease activity through a 24-week intervention.
Key facts
- Study ID
- NCT02620514
- Run by
- Emory University
- People needed
- 77
- Starts
- 2015-06-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2018-10-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- New or existing diagnosis of inflammatory bowel disease (IBD) proven via endoscopy, pathology, and radiology findings
- Maintained or started on a medication for inflammatory bowel disease at the time of enrollment
- Ability to speak English
- Good hearing
- Phone availability
You may not qualify if…
- Pregnancy or plans to be pregnant
- Inability to make own health care decisions
- Inability to participate in the study phone calls
- Uncontrolled psychiatric illness
- Enrollment in another clinical trial outside of the standard clinic IBD registry
Where it is running
- The Emory Clinic — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.